From Drug Benefit News - Earlier this month, rumors of a possible sale of Humana Inc.’s PBM division began swirling after TheStreet.com said the insurer was evaluating strategic options for Humana Pharmacy Solutions and suggested that the PBM could be gobbled up for as much as $7 billion by Catamaran Corp., CVS Caremark Corp. or Express Scripts Holding Co. But while speaking at a recent health care conference, Humana President and CEO Bruce Broussard appeared to favor an outsourcing arrangement to create a more efficient in-house PBM rather than an outright sale. Read more
From Drug Benefit News - The increased use and spend associated with compounded medications has become a hot-button topic in recent months as payers have noticed these therapies creeping into their top 10 drug spend lists and Express Scripts Holding Co. reported that utilization among its clients jumped 30% in 2013 (DBN 4/18/14, p. 1). Similarly, Catamaran Corp. Read more
From Specialty Pharmacy News - The FDA continued to add to its series of biosimilar documents with the May release of the draft guidance Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product. And while it may be at least another year or two before the first biosimilar drugs enter the U.S. marketplace, payers can look to this guidance — as well as others the FDA has issued — now to… Read more
Check out all of the benefits, sample issues & more!